Exhalace

Exhalace is a term used in respiratory metabolomics to refer to a notional class of volatile organic compounds detected in exhaled breath. It denotes breath-borne metabolites thought to originate from systemic or airway metabolism and to reflect physiological or pathophysiological states. In many studies, exhalace represents a collective signal of several VOCs rather than a single identified molecule; its exact identities can vary by cohort and instrument.

Origin and usage: The concept arises from breath research that profiles exhaled compounds to obtain noninvasive metabolic insight. The name blends exhale with a generic -ace suffix to denote a compound class released during expiration. Because exhalace often refers to related VOCs, researchers emphasize relative changes in concentration rather than absolute values.

Measurement and interpretation: Exhalace levels are measured with techniques such as GC-MS, PTR-MS, or real-time electronic noses. Interpretation considers airway inflammation, oxidative stress, diet, smoking, environmental exposures, and exercise. Normalization to end-tidal breath and standardized collection are important for comparability.

Applications and status: Exhalace remains primarily a research construct used to illustrate breath-based biomarkers. Potential applications include noninvasive screening for asthma, COPD, infectious states, and metabolic disorders, or monitoring treatment response. Due to variability and lack of standardized references, exhalace has not become routine in clinical practice.

See also: Exhaled breath analysis, volatile organic compounds, breathomics.